Remove 2007 Remove Drugs Remove Testimonials
article thumbnail

Let's Quit Sugar With Audiobook – Let's Quit Sugar

The Pharma Data

Testimonials are not necessarily representative of all of those who will use our products. Some of our testimonials are provided by customers who have received promotional offers in exchange for their participation. The testimonials displayed are given verbatim except for correction of grammatical or typing errors. 2012.11.002.

Disease 52
article thumbnail

Fatty Liver Case Study cb | Blue Heron Health News

The Pharma Data

According to the Centre for Disease Control and Prevention, the number of deaths caused by liver disease and cirrhosis has risen every year since 2007. There are no drugs for this. Testimonial / Case Study Legal Disclaimer: The story, testimonials, and case studies discussed on this page may be unique. No tablet to take.

Doctors 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Malarkey ? The Ten Worst Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Speaking of cold and darkness, it is now time for us to look back upon the results of drug and medical device litigation during 2023 and to select the ten worst decisions of the year. 2023), was the Fifth Circuit’s blatantly politicized attack on the FDA’s regulation of abortion-related drugs. FDA , 78 F.4th 4th 210 (5th Cir.

article thumbnail

Ruling On Motion To Dismiss In A Pennsylvania (Prescription) Device Case Takes Us Back

Drug & Device Law

1996), which rejected strict liability in a prescription drug case, to cases over prescription medical devices. 2014), a prescription drug case. What followed was a bizarre discourse on how drugs are “intrinsically dangerous” because they “are comprised of biologics meant to interact with and have an effect upon human tissue.”

article thumbnail

The FDA and Feasible Alternative Designs

Drug & Device Law

Drug manufacturers often could trade a little less efficacy for a little more safety, but the safest design is not always the best one. to determine whether a proposed alternative drug would have received FDA approval.” For physicians to prescribe such a safer drug, it must reach the market. Wyeth LLC , 562 U.S. 2d 506 (N.Y.

FDA 59
article thumbnail

Unimpressed Learned Intermediaries Defeat Warning Causation

Drug & Device Law

That means that prescribers can make risk/benefit analyses to determine what prescription drugs or medical devices their patients need. The prescriber’s] testimony, however, does not establish that he would have altered his prescribing conduct. That “common and widely known side effect” of many “chemotherapy drugs,” id.

article thumbnail

Can Experts Rely on Google?

Drug & Device Law

at 287 (citing transcript of expert’s testimony). [A]t A]t first blush, [the expert’s] testimony. No other witness offered testimony on these unidentified standards. An excellent example is the Sherman case, which involved junk science causation testimony in what we call a “toxic soup” chemical exposure case. Boulle, Ltd.